Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript

Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript

Seeking Alpha • 21 hours ago

Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available

Reduces investigative workloads from weeks to minutes accelerating investigations like never before TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 10, 2026 /PRNewswire/ -- Cellebrite DI Ltd.

PRNewsWire • Jun 10, 2026

Cellebrite Announces Upcoming Investor Events on June 10, 2026

TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ -- Cellebrite DI Ltd.

PRNewsWire • Jun 5, 2026

3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market

Credo is evolving into a full-stack AI connectivity leader through silicon photonics. Cellebrite's recurring revenue and government ties create a powerful competitive moat.

The Motley Fool • Jun 5, 2026

Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows

Cellebrite DI NASDAQ: CLBT executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal authorization expected to shape its next phase of growth.

MarketBeat • May 28, 2026

CGNT vs. CLBT: Which Intelligence Software Stock Offers Better Upside?

Cognyte and Cellebrite are riding AI-driven investigative demand - dig into their growth, profitability, valuation and risks to see which offers better upside.

Zacks Investment Research • May 25, 2026

Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth

Cellebrite DI NASDAQ: CLBT executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial intelligence and defense-focused capabilities, during a JPMorgan cybersecurity and DevOps event hosted by analyst Brian Essex.

MarketBeat • May 19, 2026

Cellebrite DI Ltd. (CLBT) Presents at J.P.

Cellebrite DI Ltd. (CLBT) J.P. Morgan 54th Annual Global Technology, Media and Communications Conference May 18, 2026 3:30 PM EDT

Seeking Alpha • May 18, 2026

Cellebrite: Positive Q1 Results, But There Is Room For Margin Improvements

Cellebrite delivered strong Q1 2026 results, with 19% revenue growth and notable subscription and ARR gains, beating analyst expectations. CLBT expanded its portfolio with the SCG Canada acquisition and launched AI-powered solutions, positioning itself for long-term growth and broader market reach. Despite robust top-line growth, gross, operating, and net margins declined; margin expansion remains a key area to monitor.

Seeking Alpha • May 16, 2026

Cellebrite DI Q1 Earnings Call Highlights

Cellebrite DI NASDAQ: CLBT reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives highlighted a wave of new product launches centered on artificial intelligence, cloud-based case management and mobile device access.

MarketBeat • May 14, 2026